Cargando…
No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT
BACKGROUND: Mesolimbic and nigrostriatal dopaminergic pathways play important roles in both the rewarding and conditioning effects of drugs. The dopamine transporter (DAT) is of central importance in regulating dopaminergic neurotransmission and in particular in activating the striatal D(2)-like rec...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671201/ https://www.ncbi.nlm.nih.gov/pubmed/23688063 http://dx.doi.org/10.1186/2191-219X-3-39 |
_version_ | 1782271945152135168 |
---|---|
author | Thomsen, Gerda Knudsen, Gitte Moos Jensen, Peter S Ziebell, Morten Holst, Klaus K Asenbaum, Susanne Booij, Jan Darcourt, Jacques Dickson, John C Kapucu, Özlem L Nobili, Flavio Sabri, Osama Sera, Terez Tatsch, Klaus Tossici-Bolt, Livia Laere, Koen Van Borght, Thierry Vander Varrone, Andrea Pagani, Marco Pinborg, Lars Hageman |
author_facet | Thomsen, Gerda Knudsen, Gitte Moos Jensen, Peter S Ziebell, Morten Holst, Klaus K Asenbaum, Susanne Booij, Jan Darcourt, Jacques Dickson, John C Kapucu, Özlem L Nobili, Flavio Sabri, Osama Sera, Terez Tatsch, Klaus Tossici-Bolt, Livia Laere, Koen Van Borght, Thierry Vander Varrone, Andrea Pagani, Marco Pinborg, Lars Hageman |
author_sort | Thomsen, Gerda |
collection | PubMed |
description | BACKGROUND: Mesolimbic and nigrostriatal dopaminergic pathways play important roles in both the rewarding and conditioning effects of drugs. The dopamine transporter (DAT) is of central importance in regulating dopaminergic neurotransmission and in particular in activating the striatal D(2)-like receptors. Molecular imaging studies of the relationship between DAT availability/dopamine synthesis capacity and active cigarette smoking have shown conflicting results. Through the collaboration between 13 SPECT centres located in 10 different European countries, a database of FP-CIT-binding in healthy controls was established. We used the database to test the hypothesis that striatal DAT availability is changed in active smokers compared to non-smokers and ex-smokers. METHODS: A total of 129 healthy volunteers were included. Subjects were divided into three categories according to past and present tobacco smoking: (1) non-smokers (n = 64), (2) ex-smokers (n = 39) and (3) active smokers (n = 26). For imaging of the DAT availability, we used [(123)I]FP-CIT (DaTSCAN) and single photon emission computed tomography (SPECT). Data were collected in collaboration between 13 SPECT centres located in 10 different European countries. The striatal measure of DAT availability was analyzed in a multiple regression model with age, SPECT centre and smoking as predictor. RESULTS: There was no statistically significant difference in DAT availability between the groups of active smokers, ex-smokers and non-smokers (p = 0.34). Further, we could not demonstrate a significant association between striatal DAT and the number of cigarettes per day or total lifetime cigarette packages in smokers and ex-smokers. CONCLUSION: Our results do not support the hypothesis that large differences in striatal DAT availability are present in smokers compared to ex-smokers and healthy volunteers with no history of smoking. |
format | Online Article Text |
id | pubmed-3671201 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer |
record_format | MEDLINE/PubMed |
spelling | pubmed-36712012013-06-06 No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT Thomsen, Gerda Knudsen, Gitte Moos Jensen, Peter S Ziebell, Morten Holst, Klaus K Asenbaum, Susanne Booij, Jan Darcourt, Jacques Dickson, John C Kapucu, Özlem L Nobili, Flavio Sabri, Osama Sera, Terez Tatsch, Klaus Tossici-Bolt, Livia Laere, Koen Van Borght, Thierry Vander Varrone, Andrea Pagani, Marco Pinborg, Lars Hageman EJNMMI Res Original Research BACKGROUND: Mesolimbic and nigrostriatal dopaminergic pathways play important roles in both the rewarding and conditioning effects of drugs. The dopamine transporter (DAT) is of central importance in regulating dopaminergic neurotransmission and in particular in activating the striatal D(2)-like receptors. Molecular imaging studies of the relationship between DAT availability/dopamine synthesis capacity and active cigarette smoking have shown conflicting results. Through the collaboration between 13 SPECT centres located in 10 different European countries, a database of FP-CIT-binding in healthy controls was established. We used the database to test the hypothesis that striatal DAT availability is changed in active smokers compared to non-smokers and ex-smokers. METHODS: A total of 129 healthy volunteers were included. Subjects were divided into three categories according to past and present tobacco smoking: (1) non-smokers (n = 64), (2) ex-smokers (n = 39) and (3) active smokers (n = 26). For imaging of the DAT availability, we used [(123)I]FP-CIT (DaTSCAN) and single photon emission computed tomography (SPECT). Data were collected in collaboration between 13 SPECT centres located in 10 different European countries. The striatal measure of DAT availability was analyzed in a multiple regression model with age, SPECT centre and smoking as predictor. RESULTS: There was no statistically significant difference in DAT availability between the groups of active smokers, ex-smokers and non-smokers (p = 0.34). Further, we could not demonstrate a significant association between striatal DAT and the number of cigarettes per day or total lifetime cigarette packages in smokers and ex-smokers. CONCLUSION: Our results do not support the hypothesis that large differences in striatal DAT availability are present in smokers compared to ex-smokers and healthy volunteers with no history of smoking. Springer 2013-05-20 /pmc/articles/PMC3671201/ /pubmed/23688063 http://dx.doi.org/10.1186/2191-219X-3-39 Text en Copyright ©2013 Thomsen et al.; licensee Springer. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Thomsen, Gerda Knudsen, Gitte Moos Jensen, Peter S Ziebell, Morten Holst, Klaus K Asenbaum, Susanne Booij, Jan Darcourt, Jacques Dickson, John C Kapucu, Özlem L Nobili, Flavio Sabri, Osama Sera, Terez Tatsch, Klaus Tossici-Bolt, Livia Laere, Koen Van Borght, Thierry Vander Varrone, Andrea Pagani, Marco Pinborg, Lars Hageman No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT |
title | No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT |
title_full | No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT |
title_fullStr | No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT |
title_full_unstemmed | No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT |
title_short | No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT |
title_sort | no difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)i]fp-cit (datscan) and spect |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671201/ https://www.ncbi.nlm.nih.gov/pubmed/23688063 http://dx.doi.org/10.1186/2191-219X-3-39 |
work_keys_str_mv | AT thomsengerda nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT knudsengittemoos nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT jensenpeters nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT ziebellmorten nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT holstklausk nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT asenbaumsusanne nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT booijjan nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT darcourtjacques nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT dicksonjohnc nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT kapucuozleml nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT nobiliflavio nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT sabriosama nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT seraterez nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT tatschklaus nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT tossiciboltlivia nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT laerekoenvan nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT borghtthierryvander nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT varroneandrea nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT paganimarco nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect AT pinborglarshageman nodifferenceinstriataldopaminetransporteravailabilitybetweenactivesmokersexsmokersandnonsmokersusing123ifpcitdatscanandspect |